Sensei biotherapeutics to present at two upcoming scientific conferences

Boston, oct. 29, 2024 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), a clinical stage company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that the company will present at two upcoming scientific conferences.
SNSE Ratings Summary
SNSE Quant Ranking